Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, noviembre 17
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Lumexa Imaging Holdings Inc
LMRI
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$14.79
Últ. Act.: Nov 16, 4:00 PM
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Lumexa Imaging Hldgs Financials
Lumexa Imaging Hldgs (LMRI) financial statements — income, revenue, gross margin and key metrics.
Ganancias:
Los beneficios de Q3 2026 se publicaron el mar nov 10th, después del cierre del mercado
Conferencia telefónica:
La conferencia telefónica más reciente comenzó a las 5:00 p. m., hace 7 días
Haz clic para ver el webcast
Earnings & Guidance News
PRO
Lumexa Imaging Holdings Raises FY2026 Adj EPS Guidance from $0.71-$0.77 to $0.86-$0.90 vs $0.77 Est; Affirms FY2026 Sales Guidance of $1.045B-$1.097B vs $1.067B Est
Lumexa Imaging Holdings (NASDAQ:LMRI) raises FY2026 Adj EPS guidance from $0.71-$0.77 to $0.86-$0.90 vs $0.77 analyst estimate. Affirms FY2026 sales outlook from $1.045 billion-$1.097 billion to $1.045 billion-$1.097
Benzinga Newsdesk
PRO
Lumexa Imaging Holdings Q3 Adj. EPS $0.26 Beats $0.18 Estimate, Sales $271.973M Beat $269.894M Estimate
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.18 by 44.44 percent. The company reported quarterly sales of $271.973 million which
Benzinga Newsdesk
PRO
Lumexa Imaging Holdings Affirms FY2026 Adj EPS Guidance of $0.71-$0.77 vs $0.62 Est; Raises FY2026 Sales Guidance from $1.045B-$1.090B to $1.045B-$1.097B vs $1.067B Est
Lumexa Imaging Holdings (NASDAQ:LMRI) affirms FY2026 Adj EPS guidance from $0.71-$0.77 to $0.71-$0.77 vs $0.62 analyst estimate. Raises FY2026 sales outlook from $1.045 billion-$1.090 billion to $1.045 billion-$1.097
Benzinga Newsdesk
PRO
Lumexa Imaging Holdings Q2 Adj. EPS $0.20 Beats $0.16 Estimate, Sales $264.200M Beat $263.113M Estimate
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.16 by 25 percent. The company reported quarterly sales of $264.200 million which beat
Benzinga Newsdesk
PRO
Lumexa Imaging Holdings Sees FY2026 Adj EPS $0.71-$0.77 vs $0.73 Est; Narrows FY2026 Sales Guidance from $1.045B-$1.097B to $1.045B-$1.090B vs $1.067B Est
Lumexa Imaging Holdings (NASDAQ:LMRI) is looking for FY2026 Adj EPS of $0.71-$0.77 vs $0.73 analyst estimate. Narrows FY2026 sales outlook from $1.045 billion-$1.097 billion to $1.045 billion-$1.090 billion vs $1.067
Benzinga Newsdesk
PRO
Lumexa Imaging Holdings Q1 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $252.500M Beat $251.004M Estimate
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.12 by 50 percent. The company reported quarterly sales of $252.500 million which beat
Benzinga Newsdesk